Akwel SA (AKW)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 6.200 |
|---|---|
| 52-week range | 5.500 – 10.678 |
| Return, 1 month / 3 months | +0.0% / −7.5% |
| Return, 1 year / 3 years | −34.2% / −51.1% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -46.4% |
| Average daily value traded | 0.04M EUR |
| Dividend yield | 4.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Akwel is a French automotive supplier that designs and makes components for cars and trucks. Its products include fluid management systems such as fuel and cooling lines, mechanisms for opening and closing parts of vehicles, and structural and safety-related parts. The company supplies vehicle manufacturers and their suppliers, with production and engineering sites in France and other countries. It is based in France and serves automotive markets internationally.
On this site Akwel SA appears as a stock on the Euronext Paris (France), code AKW, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Akwel SA (AKW) trades on the Euronext Paris in France. It last closed at EUR 6.200 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 387 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.2% and over the last three months it fell 7.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.4% | ||
| From 52-week high | -41.7% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.5% | ||
| 6-month return | -11.3% | ||
| 12-month return, skipping the last month | -34.2% | ||
| Risk (lower is better) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 33.1% | ||
| Worst drawdown (1 year) | -46.4% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.04M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Risk (lower is better): Volatile, with deep drawdowns.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | +0.0% |
| 3 months | −7.5% |
| 6 months | −11.3% |
| 1 year | −34.2% |
| 3 years | −51.1% |
| 5 years | −67.0% |
Signals
| 50-day / 200-day average | 6.407 / 6.847 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.175 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jun 2026 | EUR 0.3000 |
| 3 Oct 2025 | EUR 0.3000 |
| 30 Jun 2025 | EUR 0.3000 |
| 3 Jun 2024 | EUR 0.3000 |
| 8 Jun 2023 | EUR 0.3000 |
| 8 Jun 2022 | EUR 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.